Modulation of NKT cell activity with antigen-loaded CDId molecules

Details for Australian Patent Application No. 2008219020 (hide)

Owner Vaccinex, Inc.

Inventors Donda, Alena; Mach, Jean-Pierre; Stirnemann, Kathrin

Agent Callinan

Pub. Number AU-A-2008219020

PCT Pub. Number WO2008/103392

Priority 60/890,964 21.02.07 US

Filing date 21 February 2008

Wipo publication date 28 August 2008

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 4/00 (2006.01) Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/103392 Priority application(s): WO2008/103392

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008219027-Anti-theft ink tag

2008219007-Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist